Study of telomeric length in ovarian epithelial carcinoma;Análisis de la longitud telomérica en el carcinoma epitelial de ovario

Medicina Clinica

Volumn 110, Issue 15, 1998, Pages 561-565

  Aldea, Ana Isabel ^a   Barnadas, Agustí ^a   Tarrats, Antoni ^a   Vaquero, Manuel ^a   Muñoz, Concepción ^a   Krugger, Matthias ^a   Monzó, Mariano ^a   Rosell, Rafael ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CARCINOMA; COMPARATIVE STUDY; CYSTADENOCARCINOMA; DENSITOMETRY; FEMALE; GENETICS; HISTOLOGY; HUMAN; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SOUTHERN BLOTTING; STATISTICAL ANALYSIS; TELOMERE;

BLOTTING, SOUTHERN; CARCINOMA; CYSTADENOCARCINOMA, PAPILLARY; DATA INTERPRETATION, STATISTICAL; DENSITOMETRY; FEMALE; HISTOLOGICAL TECHNIQUES; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES; TELOMERASE; TELOMERE;

EID: 0032474043     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Young R, Pérez C, Hoskins W. Ovarian cancer. En: De Vita V, Hellman S, Rosenberg S, editores. Cancer, principles and practice of oncology. Filadelfia: Lippincott, 1993: 1.226-1.263.
2. Canistra S. Cancer of the ovary. N Engl J Med 1993; 18: 1.550-1.559.
3. López MP. Cancer de ovario, En: Rosell R. Abad A. Monzó M. Molina F. editores. Oncología Medica. Madrid: Ediciones Ergon, 1995; 323-334.
4. Mozys RK, Buckingham JM, Cram LS, Dam M, Deaven LL, Jones MD et al. A highly conserved repetitive DNA sequence (TTAGGG). presente at telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6.622-6.626.
5. Zakian VA. Structure and function of telomeres. Annu Rev Genet 1989; 23: 579-604.
6. Blackburn EH. Structure and function of telomeres. Nature (Lond) 1991; 350: 569-573.
7. 11. Nature (Lond) 1990; 346: 868-871.
8. Day JP, Marder BA, Morgan WF. Telomeres and their possible role in chromosome stabilization. Environ Mol Mutagen 1993; 22: 245-249.
9. Mettzer PS, Guan X-Y, Trent JM. Telomere structure stabilizes chromosome breakage. Nat Genet 1993; 4: 252-255.
10. De Lange T. Human telomeres are attached to the nuclear matrix. EMBO J 1992; 11: 717-72.
11. Shay JW, Wright WE, Werbin H. Loss of telomeric DNA during aging predispose cells to cancer [revisión]. Int J Oncol 1993; 3: 559-563.
12. Blackburn EH. Telomeres: no end in sight [revisión]. Cell 1994; 77: 621-623
13. Watson JD. Origin of concatenameric T4 DNA. Nature New Biol 1972; 239: 197-201.
14. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature (Lond) 1990; 345: 458-460.
15. Countr CM, Avilion AA, Le Feuvre CE. Steward NG, Greider CW, Harley CB et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1.921-1.929.
16. Lindsey J. Mc Gill NI, Lindsey LA, Green DK, Cooke HJ. In vivo loss of telomeric repeats with age in humans. Mutat Res 1991; 256: 45-48.
17. Levi MZ, Allsop RC, Futcher AB, Greider CW, Harley CB Telomere end-replication problem and cell aging. J Mol Biol 1992; 225: 951-960.
18. Lingner J, Promisedl J, Cach TR. Telomerase and DNA end replication: no longer a lagging strand problem? Science 1995; 269: 1.533-1.534.
19. Harley CB. Telomere loss: mitotic clock or genetic bomb? Mutat Res 1991; 256: 271-282.
20. Hiyama E, Hiyama K, Yokoyama T. Ichikawa T. Matsuura Y. Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics. Jpn J Cancer Res 1992; 83: 159-164.
21. Harley CB, Vaziri H, Counter CM, Allsop RC. The telomere hypothesis of cellular aging. Exp Gerontol 1992; 27: 375-382.
22. Wright WE, Piatyszek MA, Rainey WE, Byrd W. Shay JW. Telomerase activity in human germline and embryonic tissues and cells Dev Gen 1996; 18: 173-179.
23. Shay JW, Werbin WE, Wright WE. Telomere shortening may contribute to aging and cancer: a perspective. Mol Cell Diff 1994; 2: 1-21.
24. Blackburn EH. Telomeres and their synthesis Science 1990; 249: 489-490.
25. Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54: 3.557-3.560.
26. Hiyama K, Ishioka S, Shirotani Y, Inai K, Hiyama K, Murkami I et al. Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 1995; 10: 937-944.
27. Shiroyani Y, Hiyama K, Ishioka S, Awaya Y, Yonehara S et al. Alteration in length of telomeric repeats in lung cancer. Lung Cancer 1994; 11: 29-41.
28. Wright WE, Shay JW. The two-stage mechanism controlling cellular senescence and immortalization. Exp Gerontol 1992; 27: 375-382.
29. Adamson DJA, King DJ, Haites EN. Significant telomere shortening in childhood leukemia. Cancer Genet Cytogenet 1992, 62: 204-205.
30. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC. Telomere reduction in human colorectal carcinoma and with aging. Nature (Lond) 1990; 346: 866-868.
31. Smith JK, Yeh G. Telomere reduction in endometrial adenocarcinoma. Am J Obstet Gynecol 1992; 167: 1.883-1.887.
32. Nürnberg O, Thiel G, Weber F, Epplen JT. Changes of telomere lengths in human intracranial tumours. Hum Genet 1993; 91: 190-192.
33. Mehle C, Ljungberg B, Ross L. Telomere shortening in renal cell carcinoma. Cancer Res 1994; 54: 236-241.
34. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 1994; 91: 2.900-2.904.
35. Kitada T, Seki S, Kawakita N, Kuroki T, Monna T. Telomere shortening in chronic liver diseases. Biochem Biophys Res Commun 1995; 211: 33-39.
36. Wainwright LJ, Middleton PG, Rees JL. Changes in mean telomere length in basal cell carcinomas of the skin Genes Chromosom Cancer 1995; 12: 45-49.
37. Piatyszek MA, Kirn NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE et al. Detection of telomerase activity in human cell lines and tumors by telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1996; 17: 1-15.
38. Wright WE, Shay JW, Piatyszek MA. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensibility Nucl Acids Res 1995; 23: 3.794-3.795.
39. Kim NW, Piatzyszek MA, Prowse KR, Harley CB, Wset MD, Ho PLC et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2.011-2.015.
40. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF et al. Telomerase activity in small-cell and non small-cell lung cancers. J Natl Cancer Inst 1995; 87: 895-902.
41. Hiyama E, Yokoyama T, Tatsumoto N, Hiyama K, Imamura Y, Murakami Y et al. Telomerase activity in gastric cancer. Cancer Res 1995; 55: 3.258-3.262.
42. Chadeneau C, Hay K, Hirte HW, Gallinger S, Baccheti S. Telomerase activity associated with adquisiton of malignancy in human colorectal cancer. Cancer Res 1995; 55: 2.533-2.536.
43. Tahara H, Nakanishi T, Kitamoto M, Nakashio R, Shay JW, Tahara E et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res 1995; 55: 2.734-2.736.
44. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med 1995; 1: 249-257.
45. Hiyama E, Gollahon L, Kataoka T, Kuroi K, Yokoyama T, Gszdsr AF et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116-122.
46. Sommerfeld DJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity: a prevalent marker of malignant human prostate tissue. Cancer Res 1996; 56: 218-222.
47. Langford LA, Piatyszek MA, Xu R, Schold SC, Shay JW. Telomerase activity in brain human tumours. Lancet 1995; 346: 1.267-1.268.
48. Allshire RC, Dempster M, Hastie ND. Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 1989; 17: 4.611-4.627.
49. Sharma W, Sokoloski JA, Pérez JR, Maltere JV, Sartorelli AC, Stein AC et al. Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci USA 1995; 42: 12.343-12.346.
50. Albanell J, Man W, Mellado B, Gunawardane R Scher HI, Dmitrovsky E. Telomerase activity is repressed during differentiation of maturation-sensttive but not resistant human tumor cell lines. Cancer Res 1996; 56: 1.503-1.508.
51. Yashima K, Milchgrub S. Asfaq R, Maitra A. Slay JW, Gazdar AF, High expression of human telomerase RNA (hTR) during multistage carcinogenesis may predict for imminent invasion [resumen 2.187]. San Diego: Proceedings of Eigthy-eigth Annual Meeting. American Association for Cancer Research. 1997.
52. Shay JW, Wright WE, Telomerase activity in human cancer. Curr Opin Oncol 1996; 8: 65-71.
53. Miller AB, Hoogstraten B, Staquet M, Winkleer A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.